Novartis sells eye business to Bausch+Lomb for $2.5 billion
HQ Team July 3, 2023: Swiss drugmaker Novartis is divesting its ophthalmology assets including Xiidra, an anti-inflammatory eye drop to Bausch + Lomb,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 3, 2023: Swiss drugmaker Novartis is divesting its ophthalmology assets including Xiidra, an anti-inflammatory eye drop to Bausch + Lomb,.
HQ Team June 30, 2023: Two philanthropic health majors, Wellcome and the Bill & Melinda Gates Foundation, have come together to invest around.
HQ Team June 29, 2023: Recent research has shed new light on the connection between autism spectrum disorder (ASD) and the body’s ‘second.
HQ Team June 26, 2023: Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through.
HQ Team June 27, 2023: Any hobby with a personal meaning can ward off loneliness, a joint study found. “Loneliness are known to.
Researchers emphasize the potential benefits of short naps and the importance of maintaining overall brain health in preventing neurodegenerative conditions.
Psychiatrists have few measurement tools for depression to help make treatment decisions
HQ Team June 22, 2023: Two United States companies have announced that the FDA and the Department of Agriculture have approved their plan.
HQ Team June 22, 2023: Researchers at the University of Washington have created an app, FeverPhone, that transforms smartphones into thermometers without adding.
HQ Team June 16, 2023: Cancer has been striking young people more in recent times. A recent study in Nature dubs it the early-onset cancer.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com